The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133)

Key Points

• New interstitial lung disease cases occur frequently in systemic sclerosis patients, requiring attention.
• Key factors such as baseline HRCT results and high-risk features influence ILD onset prediction.
• Observational analysis across a cohort indicates the need for consistent screening in systemic sclerosis.
• Findings highlight the prognostic implications of early detection and treatment to improve outcomes.